ROSALIND - About the company
ROSALIND is a seed company based in San Diego (United States), founded in 2013 by Tim Wesselman. It operates as a Cloud-based collaborative bioinformatics platform for researchers. ROSALIND has raised $70K in funding from investors like Tech Coast Angels, Pasadena Angels and Wavemaker 360. The company has 821 active competitors, including 108 funded and 68 that have exited. Its top competitors include companies like Strand Life Sciences, Cellworks and BGI.
Company Details
Cloud-based collaborative bioinformatics platform for researchers. The company has developed a cloud computing software that assists with multi-omic data analysis fr drug discovery. It has features for data visualization, analysis, pathway analysis, and discovery.
- Website
- www.rosalind.bio/
- Social
- Email ID
- *****@rosalind.bio
- Phone Number
- +1 **********
Key Metrics
Founded Year
2013
Location
San Diego, United States
Stage
Seed
Total Funding
$70K in 2 rounds
Latest Funding Round
Investors
Ranked
110th among 821 active competitors
Employee Count
18 as on Jun 30, 2026
Similar Companies
Legal entities associated with ROSALIND
ROSALIND is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Rosalind, Inc. CIN: 464237817 , United States, Active | Dec 31, 1999 | - | 23 (As on Dec 31, 2024) | - |
Sign up to download ROSALIND's company profile
ROSALIND's funding and investors
ROSALIND has raised a total funding of $70K over 2 rounds. Its first funding round was on Nov 13, 2014. Its latest funding round was a Seed round on Oct 01, 2018 for $*****. 3 investors participated in its latest round. ROSALIND has 4 institutional investors.
Here is the list of recent funding rounds of ROSALIND:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 01, 2018 | 4234818 | Seed | 6796192 | 4904602 | 7145525 | 9964389 |
Nov 13, 2014 | 1234190 | Seed | 1988890 | 3951582 | 1387570 | 5039748 |
Access funding benchmarks and valuations. Sign up today!View details of ROSALIND's funding rounds and investors
ROSALIND's founders and board of directors
Founder? Claim ProfileThe founders of ROSALIND is Tim Wesselman. Tim Wesselman is the CEO of ROSALIND.
Here are the details of ROSALIND's key team members:
- Tim Wesselman: Founder & CEO of ROSALIND. Contact Info: 2 email addresses
View details of ROSALIND's Founder profiles and Board Members
ROSALIND's employee count trend
ROSALIND has 18 employees as of Jun 26. Here is ROSALIND's employee count trend over the years:
Uncover ROSALIND's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
ROSALIND's Competitors and alternates
Top competitors of ROSALIND include Strand Life Sciences, Cellworks and BGI. Here is the list of Top 10 competitors of ROSALIND, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Strand Life Sciences 2000, Bengaluru (India), Acquired | Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery | $34.9M | 73/100 | |
2nd | Cellworks 2005, San Jose (United States), Series B | Developer of a biosimulation platform | $16.5M | 66/100 | |
3rd | Provider of services in genome sequencing | - | 64/100 | ||
4th | Hexagon Bio 2017, Menlo Park (United States), Series B | Provider of bioinformatics tools for the analysis of microbial genomic sequencing data | $206M | 62/100 | |
5th | AI-based oncology therapy plan solution for professionals | $43M | 60/100 | ||
6th |  Cellanome 2020, Palo Alto (United States), Series B | Developer of the omic data platform for researchers | $119M | 59/100 | |
7th | Life Bit 2017, London (United Kingdom), Series B | AI and SaaS-based genomics analysis software for drug development | $70.9M | 56/100 | |
8th |  IMU Biosciences 2019, London (United Kingdom), Series A | Provider of immune discovery platform for precision medicines | $53M | 56/100 | |
9th | Provider of bioinformatic platforms for health management and drug development | $366M | 55/100 | ||
10th | Biostate 2023, Houston (United States), Series A | Developer of generative AI based RNAstate research platform to predict future omics states | $16M | 54/100 | |
110th |  ROSALIND 2013, San Diego (United States), Seed | Cloud-based collaborative bioinformatics platform for researchers | $70K | 35/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on ROSALIND's competitors? Click here to see the top ones
ROSALIND's Investments and acquisitions
ROSALIND has made no investments or acquisitions yet.
Reports related to ROSALIND
Here is the latest report on ROSALIND's sector:
News related to ROSALIND
•
Rebus Biosystems Partners with ROSALIND to Co-Develop Spatial Omics SoftwareBusiness Wire•Jun 08, 2022•Rebus Biosystems, ROSALIND, Rosalind
•
Platform Launches to Monitor Impact of SARS-CoV-2 Variants on COVID-19 TestsBusiness Wire•Mar 23, 2021•ROSALIND
•
•
•
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about ROSALIND
Explore our recently published companies
- Auto-Ankauf-Muehlhausen - Germany based, Unfunded company
- Inocean Technology - Richmond based, 2008 founded, Unfunded company
- Velox Mart - Gandhinagar based, 2022 founded, Unfunded company
- Nielsenretail - United Kingdom based, Unfunded company
- AFIANT - Deadpooled company
- Just one Planet - Jaipur based, 2011 founded, Unfunded company
